Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

about

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

Item

http://www.wikidata.org/entity/Q44211368

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@en

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@nl

type

Item

label

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@en

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@nl

prefLabel

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@en

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@nl

P1476

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

@en

P2093

Birutė Brasiūnienė

http://www.w3.org/2001/XMLSchema#string

Kristina Andrėkutė

http://www.w3.org/2001/XMLSchema#string

Laimonas Griškevičius

http://www.w3.org/2001/XMLSchema#string

Ramūnas Janavičius

http://www.w3.org/2001/XMLSchema#string

Ugnius Mickys

http://www.w3.org/2001/XMLSchema#string

Vilius Rudaitis

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

Histopathology of BRCA1- and BRCA2-associated breast cancer.

Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.

Validity of models for predicting BRCA1 and BRCA2 mutations

Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome.

High-resolution DNA melting analysis: advancements and limitations.

Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.

P304

409-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1524-4741.2011.01088.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51091365

http://www.w3.org/2001/XMLSchema#string

P698

21535297

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer